Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vigani

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|June 1, 1995
Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladderP Pronzato, M Landucci, F Vaira, et al.
Anticancer Research|May 1, 1994
Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patientsP Pronzato, M Landucci, F Vaira, et al.
American Journal of Clinical Oncology|November 5, 1997
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancerP Pronzato, A Vigani, F Pensa, et al.
Anticancer Research|September 1, 1995
Granisetron-dexamethasone combination for multiple day cisplatinP Pronzato, P L Losardo, F Vaira, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Carboplatin and vinorelbine in advanced non-small-cell lung cancerP Pronzato, E Ghio, P L Losardo, et al.
Breast Cancer Research and Treatment|January 1, 1997
Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancerP Pronzato, P Queirolo, M Landucci, et al.
Anticancer Research|May 1, 1997
Intensified M-VEC chemotherapy with G-CSF support as outpatient treatment for advanced bladder cancerP Pronzato, G Bertelli, F Bruna, et al.
Journal of Chemotherapy (Florence, Italy)|July 18, 2002
A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
8-methoxycaffeine-induced protein-associated DNA breaks in isolated L1210 cell nucleiG Zignaigo, A Vigani, G Billi, et al.
Anticancer Research|March 28, 2001
Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancerA Vigani, F Pensa, F Vaira, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|June 1, 1995
Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladderP Pronzato, M Landucci, F Vaira, et al.
Anticancer Research|May 1, 1994
Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patientsP Pronzato, M Landucci, F Vaira, et al.
American Journal of Clinical Oncology|November 5, 1997
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancerP Pronzato, A Vigani, F Pensa, et al.
Anticancer Research|September 1, 1995
Granisetron-dexamethasone combination for multiple day cisplatinP Pronzato, P L Losardo, F Vaira, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Carboplatin and vinorelbine in advanced non-small-cell lung cancerP Pronzato, E Ghio, P L Losardo, et al.
Breast Cancer Research and Treatment|January 1, 1997
Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancerP Pronzato, P Queirolo, M Landucci, et al.
Anticancer Research|May 1, 1997
Intensified M-VEC chemotherapy with G-CSF support as outpatient treatment for advanced bladder cancerP Pronzato, G Bertelli, F Bruna, et al.
Journal of Chemotherapy (Florence, Italy)|July 18, 2002
A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancerA Tognoni, F Pensa, F Vaira, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
8-methoxycaffeine-induced protein-associated DNA breaks in isolated L1210 cell nucleiG Zignaigo, A Vigani, G Billi, et al.
Anticancer Research|March 28, 2001
Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancerA Vigani, F Pensa, F Vaira, et al.
Pageof 4